Understanding Low Female Blood Donation Rates in the Eastern Mediterranean
Maha Badawi, Chairperson of the Hematology Department and Director of Blood Transfusion Services at King Abdulaziz University Hospital, shared on LinkedIn:
“Many blood banks in the Eastern Mediterranean region struggle with low numbers of women who successfully donate.
The issue is complex…are women afraid? Are they not interested? Are they anemic? Are they aware of the need? Are they looking for a specific donation setting?
We tried to look at this issue through the lens of Capability, Opportunity, Motivation, as prerequisites of Behavior. In this study, we focused only on the capability aspect, by following women who had the motivation and opportunity to present to the blood bank, and we studied whether they were accepted or not. If not accepted, we collected the reasons why. We then compared the results with men.
The data is simple, but it was never published before because of reasons we describe in the manuscript, related to differences in work-as-done vs work-as-prescribed per policies.
We already know that around 30% of women in our community have anemia, so the results were not surprising. Women were 12 times more likely to be deferred than men, mostly because of anemia (probably iron deficiency anemia).
We need further studies to understand the whole picture of low female donors, and even more work to address the issue of anemia and iron deficiency among women.
Grateful to the outstanding research team for allowing us to conduct this study and document these findings.”
Title: Exploring women’s capability to donate blood in a Saudi blood bank: A COM-B model study
Authors: Badawi, Maha A.; Mansory, Eman M.; Al-malki, Ahmed; Abbas, Sarah Adnan; Mutmi, Hassan; Gholam, Kholoud; Hindawi, Salwa
Read the full article here.
Stay updated with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals